ASPN Earnings & Financial Statements
Aspen Aerogels, Inc.
$5.40
+$0.24(+4.65%)
49
Overall
60
Value
54
Tech
34
Quality
Market Cap
$428.22M
Volume
1.10M
52W Range
$2.30 - $9.35
Target Price
$7.75
ASPN earnings and financial statements: Aspen Aerogels, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ASPN Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $271.10M | $452.70M | $238.72M | $180.36M | $121.62M |
| Cost of revenue | $225.10M | $269.80M | $181.80M | $175.39M | $111.69M |
| Operating income | -$378.23M | $54.53M | -$49.20M | -$79.25M | -$40.60M |
| EBITDA | -$327.65M | $43.16M | -$37.03M | -$68.41M | -$27.43M |
| Net income | -$389.55M | $13.38M | -$45.81M | -$82.74M | -$37.09M |
| EPS (diluted) | $-4.73 | $0.17 | $-0.66 | $-2.10 | $-1.22 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $406.68M | $895.14M | $703.05M | $643.42M | $182.95M |
| Total liabilities | $171.16M | $280.44M | $214.99M | $195.98M | $54.55M |
| Shareholders’ equity | $235.52M | $614.71M | $488.06M | $447.44M | $128.41M |
| Cash and equivalents | $156.90M | $220.88M | $139.72M | $281.33M | $76.56M |
| Long-term debt | $89.84M | $118.11M | $136.90M | $13.46M | $12.99M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $32.87M | $45.55M | -$42.61M | -$94.40M | -$18.63M |
| Capital expenditure | -$37.45M | -$86.26M | -$175.46M | -$177.97M | -$13.78M |
| Free cash flow | -$4.58M | -$40.71M | -$218.07M | -$272.37M | -$32.41M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ASPN | $5.40 | +4.7% | 1.10M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |